compounders sue fda over ending semaglutide shortage faces new lawsuit from wight loss drugs Hims: Why The Semaglutide Shortage

The social pressure for lighter skin in parts of Asia has even led to public health messages against overzealous skin bleaching

The fact is that these products can be sold without a prescription, directly to consumers, to make what is essentially false and misleading claims. Natures Ozempic First approved in 2005 to treat Type 2 diabetes as a twice-daily injection, GLP-1 drugs have exploded in use over the past four years and are now widely available in pill form for weight loss and diabetes

It is also in the midst of early trials for LX9851, a non-incretin obesity drug that would be a potential alternative to GLP-1s

Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases

In the multiple ascending dose study, participants receiving the highest dose level of 48 mg achieved a striking mean body-weight reduction of 9.1% by Day 54, with weight loss trends showing no signs of plateauing